Founded in 2013, IVIVA Medical builds living tissue constructs as solutions to organ failure. The company is leveraging technologies in tissue engineering, additive manufacturing, and stem cell biology to provide curative therapies. First targets are end stage renal disease (ESRD) and diabetes mellitus (DM).
